Originally, they considered that the risk of cardiovascular disease associated with obesity resulted in higher costs than covering these medications for weight loss
Our practice confirms that this medication is highly effective and safe
[DOI] [PMC free article] [PubMed] [Google Scholar] 3.McIntyre R.S., Alsuwaidan M., Baune B.T., Berk M., Demyttenaere K., Goldberg J.F., Gorwood P., Ho R., Kasper S., Kennedy S.H., et al
This fundamental pharmacokinetic difference transforms a fleeting physiological signal into a powerful therapeutic agent approved by the FDA for type 2 diabetes management and chronic weight management
In litigation filed in early 2026, a major GLP-1 manufacturer alleged that testing of compounded injectable semaglutide products found impurity levels as high as 86%, with compounded oral formulations containing impurities as high as 75%